Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Denmark
Ecuador
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
India
Ireland
Italy
Japan
Korea
Latin America
Mexico
Netherlands
Norway
Peru
Russia
South Africa
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
Venezuela
Lilly
  • Who We Are
    • Governance
      • Board of Directors
      • Executive Committee
    • Business Areas
      • Bio-Medicines
      • Diabetes
      • Oncology
    • Public Policy
      • Biosimilars
      • Health Care Reform
      • Intellectual Property
      • Trade
      • Value-Based Pricing
    • Diversity & Inclusion
      • Diversity in Clinical Trials
      • Supplier Diversity
    • Lilly Foundation
    • Grant Office
  • Caring
    • Improving Global Health
      • Patient Programs
    • Strengthening Communities
      • Giving
      • Volunteering
      • Education
    • Operating Responsibly
      • Ethics and Compliance Program
      • Transparency
  • Discovery
    • Clinical Development Pipeline
    • R&D Partnering
    • Clinical Trials
      • Clinical Trials Transparency
      • Expanded Access
    • Research Ethics
  • Products
    • Historic Products
    • HCP Medical Information
    • Patient Safety
      • Patient’s Role
      • Provider’s Role
      • FDA's Role
      • Lilly's Role
    • Anti-Counterfeiting
    • Making Safe, High-Quality Medicine
  • Careers
  • Investors
  • Partners
    • Scientific Areas of Interest
    • Scientific Partnering
  • Newsroom
    • Media Contacts
    • Blogs
    • Press Releases
      • Press Release Archives

Corporate Responsibility Reports

2018

  • Integrated Summary Report
  • United Nations Global Compact Communication on Progress
  • ERM Certification and Verification Services Assurance Statement

2017

  • Integrated Summary Report
  • United Nations Global Compact Communication on Progress
  • ERM Certification and Verification Services Assurance Statement

2016

  • Integrated Summary Report
  • United Nations Global Compact Communication on Progress

Historic

  • 2015 Integrated Report
  • 2015 Global Health Programs Report
  • 2014 Corporate Responsibility Report
  • 2012/2013 Corporate Responsibility Highlights
  • 2012/2013 Corporate Responsibility Report
  • 2011/2012 Corporate Responsibility Report
  • 2010 Corporate Responsibility Highlights
2018 Integrated Summary Report
About
Nancy’s Purpose: Supporting Cancer Survivors
Caring
Our Global Health Commitment
Caring
Global Health: 30x30 Program
Caring
Operating Responsibly
Lilly
  • Privacy Statement
  • Terms of Use
  • Diversity
  • Suppliers
  • Login
  • Sitemap
  • Contact

Copyright © 2019 Eli Lilly and Company. All rights reserved.